

Bayer has agreed to acquire vitamin company Care/of, reported Bloomberg. The news outlet noted that the transaction will put Care/of at a $225 million valuation. Care/of’s backers include Goldman Sachs, Goodwater Capital, Juxtapose, RRE Ventures and Tusk Ventures.
Source: Bloomberg